7ACE Inhibitor Myocardial Infarction Collaboative Group. Indications for ACE inhitors in the early treatment of acute myocardialinfarctim. Circulation, 1998, 97:2202-2212
8卫生部继续医药学教育委员会主编.心血管学分册.吉林:长春出版社,1999,293-297
9Lonn Em, Yusuf S, Jha P, et al. Emerging role of angiotensinconverting enzyme inhibitors in Cardiac and vascular prctection.Circulation, 1994, 90:2056-2069
1[1]Ball SG,Hall AS.Who should treated with angiotensin-converting engyme inhibitors after myocardial infarction? Am Heart J, 1996,132:244.
2[2]Soejima H,Ogawa H,Takazoe K.ACE inhibition prevents monocyte levels in patients with myocardial infarction. Circulation, 1999,100(18) :Sutplement Ⅰ-852.
3[3]Masai M, Morita M,Takahashi K,et al. ACE inhibiton improve the abnormalities of sympathetic system and recovery time dispersion after myocardial infarction. Circulation, 1998,98(17): Supplement Ⅰ-278.
4[4]Dmmbrink J-HE, Kingma JH, Hosp SA, et al. Effects of captopril on early and late arrhythmic events in patients treated with thmmbolytic therapy for first anterior myocardial infarction:The continuing story of cats. Circulatiou, 1998,98(17) :Supplement Ⅰ-279.
5[5]Bonan K,Jansson JH, Nyhlem K, et al. hnproved fibrinolysis after one year of treatment with enalapril in men and women with myocardial infarction: A possible mechanism of prognestic improtance. Circulation, 1998,98 (17): Supplement I-525.
6[6]Driss AB, Himbert C, Poiterin P, et al. Enalapril improves aterial elastic properties in rats with myocardial infarction. Circulation, 1999,100(18): Supplement Ⅰ-413.
5Manohar P, Pina IL. Therapeutic role of angiotensin Ⅱ receptor blockers in the treatment of heart failure[ J]. Mayo Clin Proc,2003,78:334- 338.
6Zannad F, All a F, Dousset B, et al. Limitation of excessive extracellular matrix tarnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure [ J ]. Cirulation ,2000, 102:2700-2706.
7Satoh M, Nakamura M,Saitoh H,et al. Aldosterone synthase ( CYP11 B2) expression and myocardial fibrosis in the failing human heart [ J ]. Clin Sci ( Lond ) ,2002,102:381-386.
8Mark A. Spironolactone for heart failure [ J ]. Med Lelt Drags Ther, 1999,41 ( 1061 ) :81-82.
9[1]Ondetti M A,Rubin B,Cushman DW. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents[J]. Science, 1977,196: 441-444.
10[2]Ondetti M A,Cushman DW. Enzymes of the renin angiotensin system and their inhibitors[J].Annu Rev Biochem, 1982,51:283-308.
